Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting - PubMed (original) (raw)

Clinical Trial

Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting

Andrea Rubboli et al. J Interv Cardiol. 2009 Aug.

Free article

Abstract

Purpose: In patients on oral anticoagulation (OAC) undergoing coronary stenting (PCI-S), procedural management and in-hospital outcome have never been specifically and prospectively investigated. Also, the contribution of early bleeding to the relevant hemorrhagic rate reported at follow-up with triple therapy of OAC, aspirin, and clopidogrel is largely unknown.

Methods: Consecutive patients with indication for OAC undergoing PCI-S at 5 centers were enrolled and prospectively evaluated.

Results: Out of 3410 patients undergoing PCI-S in the study period, indication for OAC was present in 4.8%. Femoral approach and bare metal stents were the most frequently used. During PCI-S, OAC was continued in about 30% of patients, whereas in about 20% heparin bridging was carried out. Glycoprotein IIb/IIIa inhibitors were rarely used (11%), whereas a standard bolus of unfractionated heparin was given in 93% of cases. Major adverse cardiovascular events (MACE) occurred in 4.8% of patients and major bleeding in 4.3%. No predictors of MACE or bleeding were identified, although the femoral approach was of borderline significance for major bleeding (OR 4.6, 95% CI 1.0-20.8; P = 0.05). A history of previous hemorrhage (OR 5.3, 95% CI 1.6-18.1; P = 0.007) predicted Carbofilm-coated stent implantation.

Conclusions: A limited, albeit clinically relevant, proportion of patients undergoing PCI-S has indication for OAC. Procedural management appears not substantially different from that of common patients. In-hospital major bleeding is relevant and should be taken into account when evaluating the overall hemorrhagic rate at a medium- to long-term follow-up.

PubMed Disclaimer

Cited by

Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation.
Summaria F, Sgueglia GA, D'Errico F, De Santis A, Piccioni F, Gioffrè G, Gaspardone A. Summaria F, et al. Case Rep Cardiol. 2018 Mar 5;2018:6503435. doi: 10.1155/2018/6503435. eCollection 2018. Case Rep Cardiol. 2018. PMID: 29692936 Free PMC article.
Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice.
Yan Y, Wang X, Fan JY, Nie SP, Raposeiras-Roubín S, Abu-Assi E, Simao Henriques JP, D'Ascenzo F, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song XT, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Fujii T, Correia LC, Kawashiri MA, Kedev S. Yan Y, et al. J Geriatr Cardiol. 2017 Nov;14(11):679-687. doi: 10.11909/j.issn.1671-5411.2017.11.003. J Geriatr Cardiol. 2017. PMID: 29321798 Free PMC article.
The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questions.
Rubboli A. Rubboli A. J Geriatr Cardiol. 2011 Dec;8(4):207-14. doi: 10.3724/SP.J.1263.2011.00207. J Geriatr Cardiol. 2011. PMID: 22783307 Free PMC article.
Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis.
Zhu W, Guo L, Liu F, Wan R, Shen Y, Lip GYH, Hong K. Zhu W, et al. Oncotarget. 2017 Sep 14;8(46):81154-81166. doi: 10.18632/oncotarget.20870. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113375 Free PMC article.
Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.
Puurunen M, Kiviniemi T, Nammas W, Schlitt A, Rubboli A, Nyman K, Karjalainen P, Kirchhof P, Lip GY, Airaksinen JK. Puurunen M, et al. BMJ Open. 2014 May 13;4(5):e004700. doi: 10.1136/bmjopen-2013-004700. BMJ Open. 2014. PMID: 24823675 Free PMC article.

Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting - PubMed (original) (raw)